tirzepatide sales 2024 Weight-loss drug powers Lilly results, forecast raised by $3 billion Lilly hikes revenue forecasts on

A 2025 Institute for Clinical and Economic Review (ICER) report notes that weekly GLP-1s like semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound) have become more cost-effective over time due to price reductions and proven long-term benefits ( [11] )

Tirzepatides primary function is to regulate blood sugar levels and slow digestion

Varying the lag period, the adjusted HR vs sulfonylureas was 1.09 (95% CI 0.88, 1.33) for DPP4 inhibitors and 1.11 (95% CI 0.83, 1.49) for GLP-1-receptor agonists without a lag period and 1.11 (95% CI 0.85, 1.45) for DPP4 inhibitors and 1.06 (95% CI 0.72, 1.57) for GLP-1-receptor agonists with a 2 year lag period

Krishnan A, Venkataraman J (2011) Prevalence of nonalcoholic fatty liver disease and its biochemical predictors in patients with type-2 diabetic mellitus